Abstracts from The Aerosol Society Drug Delivery to the Lungs 32
Journal of Aerosol Medicine and Pulmonary Drug Delivery
; 35(2), 2022.
Article
in English
| EMBASE | ID: covidwho-1812570
ABSTRACT
The proceedings contain 58 papers. The topics discussed include assessment of aerosol drug delivery during the escalation of treatment for a simulated COVID-19 adult patient;development of a prototype of an aerosolization device for dry powders to improve in vitro cell-based assays in the context of lung delivery;surface acoustic wave nebulization for targeted inhalation drug delivery to central and peripheral airways;nasal-pampa a novel in vitro tool for prediction of intranasal drug permeability;in vitro and in vivo evaluations of the tolerance of a new and innovative anti-tuberculosis drug combination by inhalation;transport of local anesthetic lidocaine across a pharyngeal air-liquid interface cell model;and the quantitative assessment of vape devices as novel pulmonary drug delivery systems using fluorine-18 radiolabeled drug molecules.
fluorine 18; lidocaine; tuberculostatic agent; adult; aerosol; airway; animal cell; animal experiment; animal model; conference review; controlled study; coronavirus disease 2019; drug combination; drug delivery system; drug penetration; dry powder; female; human; in vitro study; in vivo study; inhalation; lung; male; nebulization; nonhuman; pharynx; prediction; quantitative analysis; simulation
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS